These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2512329)

  • 1. Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.
    von Eckardstein A; Funke H; Henke A; Altland K; Benninghoven A; Assmann G
    J Clin Invest; 1989 Dec; 84(6):1722-30. PubMed ID: 2512329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.
    von Eckardstein A; Holz H; Sandkamp M; Weng W; Funke H; Assmann G
    J Clin Invest; 1991 May; 87(5):1724-31. PubMed ID: 2022742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A-I (Glu 198----Lys): a mutant of the major apolipoprotein of high-density lipoproteins occurring in a family with dyslipoproteinemia.
    Strobl W; Jabs HU; Hayde M; Holzinger T; Assmann G; Widhalm K
    Pediatr Res; 1988 Aug; 24(2):222-8. PubMed ID: 3141894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure.
    von Eckardstein A; Funke H; Walter M; Altland K; Benninghoven A; Assmann G
    J Biol Chem; 1990 May; 265(15):8610-7. PubMed ID: 2111322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.
    Baggio G; Manzato E; Gabelli C; Fellin R; Martini S; Enzi GB; Verlato F; Baiocchi MR; Sprecher DL; Kashyap ML
    J Clin Invest; 1986 Feb; 77(2):520-7. PubMed ID: 3944267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene.
    Pérez-Méndez O; Duhal N; Lacroix B; Bonte JP; Fruchart JC; Luc G
    Clin Chim Acta; 2006 Jun; 368(1-2):149-54. PubMed ID: 16487502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human apolipoprotein A-I polymorphism. Identification of amino acid substitutions in three electrophoretic variants of the Münster-3 type.
    Menzel HJ; Assmann G; Rall SC; Weisgraber KH; Mahley RW
    J Biol Chem; 1984 Mar; 259(5):3070-6. PubMed ID: 6421816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165-->Arg).
    von Eckardstein A; Castro G; Wybranska I; Theret N; Duchateau P; Duverger N; Fruchart JC; Ailhaud G; Assmann G
    J Biol Chem; 1993 Feb; 268(4):2616-22. PubMed ID: 8428938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.
    Weisgraber KH; Rall SC; Innerarity TL; Mahley RW; Kuusi T; Ehnholm C
    J Clin Invest; 1984 Apr; 73(4):1024-33. PubMed ID: 6323533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the apoA-IV-2 isoprotein.
    Rader DJ; Schäfer J; Lohse P; Verges B; Kindt M; Zech LA; Steinmetz A; Brewer HB
    J Clin Invest; 1993 Aug; 92(2):1009-17. PubMed ID: 8349786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-1 in umbilical cord blood of newborn infants: relation to gestational age and high-density lipoprotein cholesterol.
    Parker CR; Fortunato SJ; Carr BR; Owen J; Hankins GD; Hauth JC
    Pediatr Res; 1988 Apr; 23(4):348-51. PubMed ID: 3131725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Apolipoproteins A-I, A-II and E as well as high density lipoproteins in blood of persons with dis-alpha-lipoproteinemias].
    Denisenko AD; Usatenko MS; Lozovskiĭ VT; Triufanov VF; Oleĭnik IA
    Vopr Med Khim; 1981; 27(2):272-80. PubMed ID: 6792777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
    Rump P; Mensink RP; Hornstra G
    Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):317-24. PubMed ID: 12669678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for naturally occurring apolipoprotein A-I variants: apo A-I(delta K107) is associated with low HDL-cholesterol levels in men but not in women.
    Nofer JR; von Eckardstein A; Wiebusch H; Weng W; Funke H; Schulte H; Köhler E; Assmann G
    Hum Genet; 1995 Aug; 96(2):177-82. PubMed ID: 7635466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced fractional catabolic rate of apo A-I and apo A-II in heterozygous subjects for apo A-I(Zaragoza) (L144R).
    Recalde D; Velez-Carrasco W; Civeira F; Cenarro A; Gomez-Coronado D; Ordovas JM; Pocovi M
    Atherosclerosis; 2001 Feb; 154(3):613-23. PubMed ID: 11257262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific methionine sulfoxide formation is the structural basis of chromatographic heterogeneity of apolipoproteins A-I, C-II, and C-III.
    von Eckardstein A; Walter M; Holz H; Benninghoven A; Assmann G
    J Lipid Res; 1991 Sep; 32(9):1465-76. PubMed ID: 1753217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal lecithin:cholesterol acyltransferase activation by a human apolipoprotein A-I variant in which a single lysine residue is deleted.
    Rall SC; Weisgraber KH; Mahley RW; Ogawa Y; Fielding CJ; Utermann G; Haas J; Steinmetz A; Menzel HJ; Assmann G
    J Biol Chem; 1984 Aug; 259(16):10063-70. PubMed ID: 6432779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease.
    Miccoli R; Bertolotto A; Navalesi R; Odoguardi L; Boni A; Wessling J; Funke H; Wiebusch H; Eckardstein A; Assmann G
    Circulation; 1996 Oct; 94(7):1622-8. PubMed ID: 8840853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of human apolipoprotein A-I Fukuoka (110 Glu----Lys). A novel apolipoprotein variant.
    Takada Y; Sasaki J; Ogata S; Nakanishi T; Ikehara Y; Arakawa K
    Biochim Biophys Acta; 1990 Apr; 1043(2):169-76. PubMed ID: 2107878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.
    Schmitz G; Assmann G; Rall SC; Mahley RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6081-5. PubMed ID: 6412234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.